James L Wardell Selected Research

oxazolidine

1/2014	Mefloquine-oxazolidine derivatives: a new class of anticancer agents.
1/2012	Mefloquine-oxazolidine derivatives, derived from mefloquine and arenecarbaldehydes: In vitro activity including against the multidrug-resistant tuberculosis strain T113.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

James L Wardell Research Topics

Disease

3	Neoplasms (Cancer) 10/2015 - 01/2014
2	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 01/2012 - 10/2009
1	Chagas Disease (American Trypanosomiasis) 07/2020
1	Tuberculosis (Tuberculoses) 06/2014
1	Leukemia 09/2010

Drug/Important Bio-Agent (IBA)

2	oxazolidineIBA 01/2014 - 01/2012
2	Mefloquine (Lariam)FDA LinkGeneric 01/2014 - 01/2012
1	1,3,4-thiadiazoleIBA 07/2020
1	Pharmaceutical PreparationsIBA 07/2020
1	CamphorIBA 10/2015
1	ThiophenesIBA 06/2014
1	QuinoxalinesIBA 02/2014
1	QuinolinesIBA 01/2014
1	ThiosemicarbazonesIBA 09/2010
1	AntimonyIBA 09/2010
1	Ethambutol (Myambutol)FDA LinkGeneric 10/2009

Therapy/Procedure

1	Therapeutics 07/2020